These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 32359682)

  • 1. The impact of pregnancy on biologic therapies for the treatment of inflammatory bowel disease.
    Picardo S; Seow CH
    Best Pract Res Clin Gastroenterol; 2020; 44-45():101670. PubMed ID: 32359682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infection Risk With Biologic Therapy in Patients With Inflammatory Bowel Disease.
    Hindryckx P; Novak G; Bonovas S; Peyrin-Biroulet L; Danese S
    Clin Pharmacol Ther; 2017 Oct; 102(4):633-641. PubMed ID: 28699217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De-escalation of immunomodulator and biological therapy in inflammatory bowel disease.
    Chapman TP; Gomes CF; Louis E; Colombel JF; Satsangi J
    Lancet Gastroenterol Hepatol; 2020 Jan; 5(1):63-79. PubMed ID: 31818473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current concepts about the treatment of inflammatory bowel disease, biological therapy].
    Bosques-Padilla FJ; Galindo-Marines SL; Yamamoto-Farusho JK
    Rev Gastroenterol Mex; 2008; 73(4):217-30. PubMed ID: 19666271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
    Magro F; Portela F
    BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologic therapy in the management of extraintestinal manifestations of inflammatory bowel disease.
    Barrie A; Regueiro M
    Inflamm Bowel Dis; 2007 Nov; 13(11):1424-9. PubMed ID: 17567879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Biologic Therapy by Pregnant Women With Inflammatory Bowel Disease Does Not Affect Infant Response to Vaccines.
    Beaulieu DB; Ananthakrishnan AN; Martin C; Cohen RD; Kane SV; Mahadevan U
    Clin Gastroenterol Hepatol; 2018 Jan; 16(1):99-105. PubMed ID: 28870657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologic therapy of inflammatory bowel disease.
    Sandborn WJ; Targan SR
    Gastroenterology; 2002 May; 122(6):1592-608. PubMed ID: 12016425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Balancing the risks and benefits of biologic therapy in inflammatory bowel diseases.
    Trivedi I; Hanauer SB
    Expert Opin Drug Saf; 2015; 14(12):1915-34. PubMed ID: 26559664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologic therapies against inflammatory bowel disease: a dysregulated immune system and the cross talk with gastrointestinal mucosa hold the key.
    Dharmani P; Chadee K
    Curr Mol Pharmacol; 2008 Nov; 1(3):195-212. PubMed ID: 20021434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety issues with biological therapies for inflammatory bowel disease.
    Van Assche G; Vermeire S; Rutgeerts P
    Curr Opin Gastroenterol; 2006 Jul; 22(4):370-6. PubMed ID: 16760752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure Concentrations of Infants Breastfed by Women Receiving Biologic Therapies for Inflammatory Bowel Diseases and Effects of Breastfeeding on Infections and Development.
    Matro R; Martin CF; Wolf D; Shah SA; Mahadevan U
    Gastroenterology; 2018 Sep; 155(3):696-704. PubMed ID: 29857090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the Cautions and Contraindications of Immunomodulator and Biologic Therapies for Use in Inflammatory Bowel Disease.
    Cohn HM; Dave M; Loftus EV
    Inflamm Bowel Dis; 2017 Aug; 23(8):1301-1315. PubMed ID: 28708806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging biologic therapies in inflammatory bowel disease.
    Lim WC; Hanauer SB
    Rev Gastroenterol Disord; 2004; 4(2):66-85. PubMed ID: 15184826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory bowel disease in pregnancy.
    Kane S
    Gastroenterol Clin North Am; 2003 Mar; 32(1):323-40. PubMed ID: 12635421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pregnancy and inflammatory bowel disease].
    Asimakopoulos G
    Rev Med Chir Soc Med Nat Iasi; 2004; 108(1):46-50. PubMed ID: 15688755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologic therapy for inflammatory bowel disease.
    Ardizzone S; Bianchi Porro G
    Drugs; 2005; 65(16):2253-86. PubMed ID: 16266194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming challenges of treating inflammatory bowel disease in pregnancy.
    Gaidos JK; Kane SV
    Expert Rev Clin Immunol; 2016 Aug; 12(8):871-8. PubMed ID: 26981845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.